23 results on '"Succinylcholine"'
Search Results
2. Postoperative weakness and anesthetic-associated rhabdomyolysis in a pediatric patient: a case report and review of the literature.
- Author
-
Floridis, John and Barbour, Ruth
- Abstract
Background: Anesthesia-associated rhabdomyolysis is a rare complication of surgery that causes postoperative myalgia, weakness, and potential renal failure if not managed promptly. Predisposing conditions that may lead to this complication include muscular dystrophies and myopathies.Case Presentation: This rare case describes a pediatric non-Indigenous Australian patient developing this complication, with no known predisposing risk factors, and no clear etiology. A 9-year-old child with a background of asthma underwent an elective removal of keloid scar on her chest wall. The procedure was brief and uncomplicated, with an uneventful induction of anesthesia. During the emergence period, she developed acutely raised airway pressures with bronchospasm and laryngospasm requiring the use of salbutamol and suxamethonium with good effect. In the initial postoperative period, the patient complained of generalized myalgia and muscle weakness and was unable to mobilize independently. There was transient recovery to normal function; however, a recurrence of symptoms the following day with associated myalgias warranted admission to hospital. She was found to have rhabdomyolysis that was managed conservatively with a full recovery of several weeks. She was thoroughly investigated for any underlying cause, including genetic testing for malignant hyperthermia susceptibility (she had a variant of unknown significance but was negative for the known genetic abnormalities that cause malignant hyperthermia).Conclusion: This case report demonstrates the importance of considering anesthesia-associated rhabdomyolysis as a differential for acute postoperative weakness, and outlines an investigative approach. To the best of our knowledge, it is the first case described in the pediatric literature to report biphasic progression of symptoms. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
3. Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database.
- Author
-
Caroff, Stanley N., Roberts, Christopher B., Rosenberg, Henry, Tobin, Joseph R., Watt, Stacey, Mashman, Darlene, Riazi, Sheila, and Berkowitz, Rosalind M.
- Subjects
- *
MENTAL illness drug therapy , *AMERICAN veterans , *DANTROLENE , *DRUG efficacy , *INTRAVENOUS therapy , *RHABDOMYOLYSIS , *PSYCHIATRIC drugs , *BODY temperature , *RESEARCH methodology , *CRITICALLY ill , *RETROSPECTIVE studies , *ACQUISITION of data , *CREATINE kinase , *PATIENTS , *SEPSIS , *MALIGNANT hyperthermia , *HOSPITAL mortality , *SYMPTOMS , *MEDICAL records , *DESCRIPTIVE statistics , *RESPIRATION , *NEUROLEPTIC malignant syndrome , *COMORBIDITY - Abstract
Background: Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to document current practices in the frequency, diagnoses, clinical characteristics and outcomes associated with dantrolene treatment in critical care settings. Methods: Inpatients receiving intravenous dantrolene from October 1, 2004 to September 30, 2014 were identified retrospectively in the U.S. Veterans Health Administration national database. Extracted data included; diagnoses of hypermetabolic syndromes; triggering drugs; dantrolene dosages; demographics; vital signs; laboratory values; in-hospital mortality; complications; and lengths of stay. Frequency and mortality of patients who did not receive dantrolene were obtained in selected diagnoses for exploratory comparisons. Results: Dantrolene was administered to 304 inpatients. The most frequent diagnoses associated with dantrolene treatment were neuroleptic malignant syndrome (NMS; N = 108, 35.53%) and sepsis (N = 47, 15.46%), with MH accounting for only 13 (4.28%) cases. Over half the patients had psychiatric comorbidities and received psychotropic drugs before dantrolene treatment. Common clinical findings in patients receiving dantrolene included elevated temperature (mean ± SD; 38.7 ± 1.3 °C), pulse (116.33 ± 22.80/bpm), respirations (27.75 ± 9.58/min), creatine kinase levels (2,859.37 ± 6,646.88 IU/L) and low pO2 (74.93 ± 40.16 mmHg). Respiratory, renal or cardiac failure were common complications. Mortality rates in-hospital were 24.01% overall, 7.69% in MH, 20.37% in NMS and 42.55% in sepsis, compared with mortality rates in larger and possibly less severe groups of unmatched patients with MH (5.26%), NMS (6.66%), or sepsis (41.91%) who did not receive dantrolene. Conclusions: In over 95% of cases, dantrolene administration was associated with diagnoses other than MH in critically-ill patients with hypermetabolic symptoms and medical and psychiatric comorbidities. Exploratory survey data suggested that the efficacy and safety of dantrolene in preventing mortality in hypermetabolic syndromes other than MH remain uncertain. However, randomized and controlled studies using standardized criteria between groups matched for severity are essential to guide practice in using dantrolene. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients.
- Author
-
Heiderich, Sebastian, Thoben, Christian, Dennhardt, Nils, Krauß, Terence, Sümpelmann, Robert, Zimmermann, Stefan, Reitz, Michael, and Rüffert, Henrik
- Subjects
- *
MEDICAL equipment contamination , *DECONTAMINATION (From gases, chemicals, etc.) , *CHARCOAL , *MALIGNANT hyperthermia , *MEDICAL protocols , *GAS chromatography , *SEVOFLURANE , *SPECTRUM analysis , *PREVENTION ,ANESTHESIA equipment - Abstract
Background: Patients at risk of malignant hyperthermia need trigger-free anesthesia. Therefore, anesthesia machines prepared for safe use in predisposed patients should be free of volatile anesthetics. The washout time depends on the composition of rubber and plastic in the anesthesia machine. Therefore, new anesthesia machines should be evaluated regarding the safe preparation for trigger-free anesthesia. This study investigates wash out procedures of volatile anesthetics for two new anesthetic workstations: Dräger Atlan A350 and General Electric Healthcare (GE) Carestation 650 and compare it with preparation using activated charcoal filters (ACF). Methods: A Dräger Atlan and a Carestation 650 were contaminated with 4% sevoflurane for 90 min. The machines were decontaminated with method (M1): using ACF, method 2 (M2): a wash out method that included exchange of internal parts, breathing circuits and soda lime canister followed by ventilating a test lung using a preliminary protocol provided by Dräger or method 3 (M3): a universal wash out instruction of GE, method 4 (M4): M3 plus exchange of breathing system and bellows. Decontamination was followed by a simulated trigger-free ventilation. All experiments were repeated with 8% desflurane contaminated machines. Volatile anesthetics were detected with a closed gas loop high-resolution ion mobility spectrometer with gas chromatographic pre-separation attached to the bacterial filter of the breathing circuits. Primary outcome was time until < 5 ppm of volatile anesthetics and total preparation time. Results: Time to < 5 ppm for the Atlan was 17 min (desflurane) and 50 min (sevoflurane), wash out continued for a total of 60 min according to protocol resulting in a total preparation time of 96-122 min. The Carestation needed 66 min (desflurane) and 24 min (sevoflurane) which could be abbreviated to 24 min (desflurane) if breathing system and bellows were changed. Total preparation time was 30-73 min. When using active charcoal filters time to < 5 ppm was 0 min for both machines, and total preparation time < 5 min. Conclusion: Both wash out protocols resulted in a significant reduction of trace gas concentrations. However, due to the complexity of the protocols and prolonged total preparation time, feasibility in clinical practice remains questionable. Especially when time is limited preparation of the anesthetic machines using ACF remain superior. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Adequacy of maternal anesthesia depth with two sodium thiopental doses in elective caesarean section: a randomized clinical trial.
- Author
-
Sabetian, Golnar, Zand, Farid, Mirhadi, Fatemeh, Hadavi, Mohammad Reza, Asadpour, Elham, Dehghanpisheh, Laleh, Fattahi Saravi, Zeinabsadat, and Razavi, Seyed Mostajab
- Subjects
- *
EVALUATION of medical care , *SUCCINYLCHOLINE , *ANESTHESIA research , *THIOPENTAL , *MUSCLE contraction , *ANESTHESIA in obstetrics , *HYPNOTISM , *RANDOMIZED controlled trials , *PREGNANCY outcomes , *SEVOFLURANE , *CESAREAN section , *APGAR score - Abstract
Background: Administration of an optimal dose of anesthetic agent to ensure adequate depth of hypnosis with the lowest risk of adverse effects to the fetus is highly important in cesarean section. Sodium thiopental (STP) is still the first choice for induction of anesthesia in some countries for this obstetric surgery. We aimed to compare two doses of STP with regarding the depth of anesthesia and the condition of newborn infants. Methods: In this clinical trial, parturient undergoing elective Caesarian section were randomized into two groups receiving either low-dose (5 mg/kg) or high-dose (7 mg/kg) STP. Muscle relaxation was provided with succinylcholine 2 mg/kg and anesthesia was maintained with O2/N2O and sevoflurane. The depth of anesthesia was evaluated using isolated forearm technique (IFT) and bispectral index (BIS) in various phases. Additionally, infants were assessed using Apgar score and neurobehavioral test. Results: Forty parturient were evaluated in each group. BIS was significantly lower in high-dose group at skin incision to delivery and subcutaneous and skin closure. Also, significant differences were noticed in IFT over induction to incision and incision to delivery. Apgar score was significantly lower in high-dose group at 1 min after delivery. Newborn infants in low-dose group had significantly better outcomes in all three domains of the neurobehavioral test. Conclusion: 7 mg/kg STP is superior to 5 mg/kg in creating deeper hypnosis for mothers. However, it negatively impacts Apgar score and neurobehavioral test of neonates. STP seems to has dropped behind as an acceptable anesthetic in Cesarean section. Trial registration: IRCT No: 2016082819470 N45, 13/03/2019. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Assessment of remifentanil for rapid sequence induction and intubation in patients at risk of pulmonary aspiration of gastric contents compared to rapid-onset paralytic agents: study protocol for a non-inferiority simple blind randomized controlled trial (the REMICRUSH study).
- Author
-
Grillot, Nicolas, Garot, Matthias, Lasocki, Sigismond, Huet, Olivier, Bouzat, Pierre, Le Moal, Charlène, Oudot, Mathieu, Chatel-Josse, Nolwenn, El Amine, Younes, Danguy des Déserts, Marc, Bruneau, Nathalie, Cinotti, Raphael, David, Jean-Stéphane, Langeron, Olivier, Minville, Vincent, Tching-Sin, Martine, Faurel-Paul, Elodie, Lerebourg, Céline, Flattres-Duchaussoy, Delphine, and Jobert, Alexandra
- Subjects
- *
REMIFENTANIL , *RESPIRATORY aspiration , *TRACHEA , *TRACHEA intubation , *INTUBATION , *HYPNOTICS , *RANDOMIZED controlled trials - Abstract
Background: Rapid-onset paralytic agents are recommended to achieve muscle relaxation and facilitate tracheal intubation during rapid sequence induction in patients at risk of pulmonary aspiration of gastric contents. However, opioids are frequently used in this setting. The study's objective is to demonstrate the non-inferiority of remifentanil compared to rapid-onset paralytic agents, in association with an hypnotic drug, for tracheal intubation in patients undergoing procedure under general anesthesia and at risk of pulmonary aspiration of gastric contents.Methods: The REMICRUSH (Remifentanil for Rapid Sequence Induction of Anaesthesia) study is a multicenter, single-blinded, non-inferiority randomized controlled trial comparing remifentanil (3 to 4 μg/kg) with rapid-onset paralytic agents (succinylcholine or rocuronium 1 mg/kg) for rapid sequence induction in 1150 adult surgical patients requiring tracheal intubation during general anesthesia. Enrolment started in October 2019 in 15 French anesthesia units. The expected date of the final follow-up is October 2021. The primary outcome is the proportion of successful tracheal intubation without major complications. A non-inferiority margin of 7% was chosen. Analyses of the intent-to-treat and per-protocol populations are planned.Discussion: The REMICRUSH trial protocol has been approved by the ethics committee of The Comité de Protection des Personnes Sud-Ouest et Outre-Mer II and will be carried out according to the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. The results of this study will be disseminated through presentations at scientific conferences and publications in peer-reviewed journals. The REMICRUSH trial is the first randomized controlled trial powered to investigate whether remifentanil with hypnotics is non-inferior to rapid-onset paralytic agents with hypnotic in rapid sequence induction of anesthesia for full stomach patients considering successful tracheal intubation without major complication.Trial Registration: ClinicalTrials.gov NCT03960801. Registered on May 23, 2019. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
7. Prolonged apnea after ECT in organophosphorus poisoning – the need to redefine norms.
- Author
-
Sasidharan, Shibu and Dhillon, Harpreet Singh
- Subjects
- *
POISONING , *APNEA , *DRUG receptors , *ELECTROCONVULSIVE therapy , *PSYCHIATRIC diagnosis - Abstract
Background: Poisoning and deaths by organo-phosphorous (OP) compounds are one of the major causes of death in developing and poor countries, and a common admission in the emergency ward and the ICU. OP compounds act by irreversibly binding to pseudocholinesterase enzyme and hence prolong the apnea in patients being given suxamethonium. We present a unusual case of OP poisoning (OPP) in which prolonged apnea ensued in a patient of severe depression following MECT (modified electroconvulsive therapy) in which suxamethonium was used as muscle relaxant, in whom we were cautious of the side-effect of prior organophosphorus poisoning. Since the cases of OPP are very high worldwide, a thorough knowledge of the interaction of the action of the drug and the receptors on which it acts takes pride of place. This article highlights the nuances in the field of psychiatry and anaesthesia in diagnosis and management of prolonged apnea after ECT. Case presentation: A 53/F patient consumed OP 38 days prior to MECT. Since existing literature recommend a delay of 4 weeks and a subminimal dose of suxamethonium to prevent prolonged apnea, both these points were taken into consideration. Despite 38 days post exposure to OP, and a dose of succinylcholine of < 0.3 mg/kg, the patient remained apneic for 3 h. Suxamethionum apnea was managed with elective ventilation. After recovery, patient had no residual effect. Subsequently her pseudocholinesterase levels were done which were found to be very low. Conclusion: This case is being presented to emphasize that behaviour of post synaptic receptors cannot be relied upon after OP poisoning and pseudocholinesterase levels needs to be mandatorily checked, irrespective of duration post-exposure. In strong suspects dibucaine number and fluoride number also needs to be estimated. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. The optimal dose of succinylcholine for rapid sequence induction: a systematic review and meta-analysis of randomized trials.
- Author
-
Putzu, Alessandro, Tramèr, Martin R., Giffa, Maxim, and Czarnetzki, Christoph
- Subjects
- *
ANESTHESIOLOGISTS , *APNEA , *DOSE-effect relationship in pharmacology , *META-analysis , *RESPIRATION , *TRACHEA intubation , *SYSTEMATIC reviews , *BODY mass index , *GENERAL anesthesia , *SUCCINYLCHOLINE - Abstract
Background: The evidence base for the widely accepted standard regimen of succinylcholine for rapid sequence induction (1.0 mg kg− 1) remains unclear. Methods: We performed a systematic review and meta-analysis of randomized trials comparing any succinylcholine regimen with the standard regimen (1.0 mg kg− 1) and reporting on intubating conditions and/or apnoea times. Results were expressed as absolute risk differences (ARD) for dichotomous data and mean differences (MD) for continuous data. Results: We retrieved six trials with relevant data of 864 patients (ASA 1 or 2, aged 18–65 years, body mass index < 30 kg m− 2). Four regimens (0.3, 0.4, 0.5, 0.6 mg kg− 1) were compared with 1.0 mg kg− 1 in at least three trials each, and three (0.8, 1.5, 2 mg kg− 1) in one each. With 0.3 to 0.5 mg kg− 1, the likelihood of excellent intubating conditions was significantly decreased (ARD − 22% to − 67%). With 0.3 and 0.4 mg kg− 1, but not with 0.5, 0.6, 0.8, 1.5 and 2.0 mg kg− 1, the likelihood of unacceptable intubating conditions was significantly increased (ARD + 22% and + 32%, respectively). With 2.0 mg kg− 1, but not with 0.8 or 1.5 mg kg− 1, the likelihood of excellent intubating conditions was significantly increased (ARD + 23%). Apnoea times were significantly shorter with regimens ≤0.8 mg kg− 1 (MD − 1.0 to − 3.4 min) but were not reported with 1.5 or 2.0 mg kg− 1. Conclusions: With succinylcholine regimens ≤0.5 mg kg− 1, excellent intubating conditions are less likely and apnoea times are shorter, compared with 1 mg kg− 1. With 0.3 and 0.4 mg kg− 1, unacceptable intubating conditions are more common. Succinylcholine 1.5 mg kg− 1 does not produce more often excellent conditions compared with 1 mg kg− 1, while 2.0 mg kg− 1 does, but the database with these regimens is weak and apnoea times remain unknown. Limited information size and strong statistical heterogeneity decrease the certainty of the evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
9. Comparison of emergence agitation between succinylcholine and rocuronium-sugammadex in adults following closed reduction of a nasal bone fracture: a prospective randomized controlled trial.
- Author
-
Lee, Seok-Jin, Sung, Tae-Yun, and Cho, Choon-Kyu
- Subjects
- *
COMPARATIVE studies , *CONFIDENCE intervals , *DELIRIUM , *FRACTURE fixation , *LONGITUDINAL method , *NASAL bone , *PHYSIOLOGIC salines , *RISK assessment , *STATISTICAL sampling , *SURGICAL therapeutics , *EFFECT sizes (Statistics) , *RANDOMIZED controlled trials , *RELATIVE medical risk , *TREATMENT effectiveness , *DISEASE incidence , *SEVERITY of illness index , *DISEASE duration , *SUGAMMADEX , *SUCCINYLCHOLINE , *ROCURONIUM bromide ,RISK of delirium - Abstract
Background: Sugammadex allows rapid recovery from rocuronium-induced neuromuscular blockade. Succinylcholine is often used for brief surgeries but is associated with myalgia, headache, histamine release, and increased lactate levels. Thus, we hypothesized that succinylcholine may affect emergence agitation (EA) and compared the effects of succinylcholine and rocuronium-sugammadex on EA in patients undergoing closed reduction of a nasal bone fracture under general anesthesia. Methods: Forty-two patients were prospectively enrolled and allocated randomly to the succinylcholine group (group SC) or the rocuronium-sugammadex group (group RS; each n = 21). Neuromuscular block and its reversal were achieved with succinylcholine and normal saline in group SC, whereas rocuronium and sugammadex were administered in group RS. After surgery, the incidence of EA as a primary outcome, the incidence of dangerous EA, and duration of EA as secondary outcomes were compared. Results: The incidence of EA was higher in group SC than in group RS (90.5% vs. 47.6%, respectively; relative risk [RR] 4.3; 95% confidence interval [CI] 1.2 to 15.7; P =.006). The incidence of dangerous EA increased in group SC compared to group RS (33.3% vs. 4.8%, respectively; RR 2.1; 95% CI 1.3 to 3.4; P =.045). The duration of agitation was longer in group SC than in group RS [106.5 (65.1) vs. 40.4 (26.0) sec; mean difference 66.1 s; 95% CI 31.0 to 101.1; effect size 1.3; P =.001). Conclusion: Succinylcholine increases the incidence, severity, and duration of EA compared to rocuronium-sugammadex in patients undergoing closed reduction of a nasal bone fracture. Trial registration: CRiS Registration number KCT0002673. Initial registration date was 31 January 2018 (Retrospectively registered). [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Detecting Succinylation sites from protein sequences using ensemble support vector machine.
- Author
-
Ning, Qiao, Zhao, Xiaosa, Bao, Lingling, Ma, Zhiqiang, and Zhao, Xiaowei
- Subjects
- *
SUCCINYLCHOLINE , *NICOTINIC acetylcholine agonists , *SUPPORT vector machines , *AMINO acid sequence , *MACHINE learning - Abstract
Background: Lysine succinylation is a new kind of post-translational modification which plays a key role in protein conformation regulation and cellular function control. To understand the mechanism of succinylation profoundly, it is necessary to identify succinylation sites in proteins accurately. However, traditional methods, experimental approaches, are labor-intensive and time-consuming. Computational prediction methods have been proposed recent years, and they are popular because of their convenience and high speed. In this study, we developed a new method to predict succinylation sites in protein combining multiple features, including amino acid composition, binary encoding, physicochemical property and grey pseudo amino acid composition, with a feature selection scheme (information gain). And then, it was trained using SVM (Support Vector Machine) and an ensemble learning algorithm. Results: The performance of this method was measured with an accuracy of 89.14% and a MCC (Matthew Correlation Coefficient) of 0.79 using 10-fold cross validation on training dataset and an accuracy of 84.5% and a MCC of 0.2 on independent dataset. Conclusions: The conclusions made from this study can help to understand more of the succinylation mechanism. These results suggest that our method was very promising for predicting succinylation sites. The source code and data of this paper are freely available at
https://github.com/ningq669/PSuccE . [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
11. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients
- Author
-
Sebastian Heiderich, Christian Thoben, Nils Dennhardt, Terence Krauß, Robert Sümpelmann, Stefan Zimmermann, Michael Reitz, and Henrik Rüffert
- Subjects
Time Factors ,Research ,Succinylcholine ,Malignant hyperthermia ,Patient safety ,Anesthesiology and Pain Medicine ,Anesthesiology ,Trigger-free anesthesia ,Charcoal ,Anesthetics, Inhalation ,Humans ,RD78.3-87.3 ,Decontamination ,Volatile anesthetics - Abstract
Background Patients at risk of malignant hyperthermia need trigger-free anesthesia. Therefore, anesthesia machines prepared for safe use in predisposed patients should be free of volatile anesthetics. The washout time depends on the composition of rubber and plastic in the anesthesia machine. Therefore, new anesthesia machines should be evaluated regarding the safe preparation for trigger-free anesthesia. This study investigates wash out procedures of volatile anesthetics for two new anesthetic workstations: Dräger Atlan A350 and General Electric Healthcare (GE) Carestation 650 and compare it with preparation using activated charcoal filters (ACF). Methods A Dräger Atlan and a Carestation 650 were contaminated with 4% sevoflurane for 90 min. The machines were decontaminated with method (M1): using ACF, method 2 (M2): a wash out method that included exchange of internal parts, breathing circuits and soda lime canister followed by ventilating a test lung using a preliminary protocol provided by Dräger or method 3 (M3): a universal wash out instruction of GE, method 4 (M4): M3 plus exchange of breathing system and bellows. Decontamination was followed by a simulated trigger-free ventilation. All experiments were repeated with 8% desflurane contaminated machines. Volatile anesthetics were detected with a closed gas loop high-resolution ion mobility spectrometer with gas chromatographic pre-separation attached to the bacterial filter of the breathing circuits. Primary outcome was time until Results Time to Conclusion Both wash out protocols resulted in a significant reduction of trace gas concentrations. However, due to the complexity of the protocols and prolonged total preparation time, feasibility in clinical practice remains questionable. Especially when time is limited preparation of the anesthetic machines using ACF remain superior.
- Published
- 2021
12. Malignant hyperthermia: a review.
- Author
-
Rosenberg, Henry, Pollock, Neil, Schiemann, Anja, Bulger, Terasa, and Stowell, Kathryn
- Subjects
- *
MALIGNANT hyperthermia , *INHALATION anesthetics , *SUCCINYLCHOLINE , *HALOTHANE , *DISEASE prevalence , *TACHYCARDIA diagnosis , *DIAGNOSIS - Abstract
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, and rarely, in humans, to stressors such as vigorous exercise and heat. The incidence of MH reactions ranges from 1:10,000 to 1: 250,000 anesthetics. However, the prevalence of the genetic abnormalities may be as great as one in 400 individuals. MH affects humans, certain pig breeds, dogs and horses. The classic signs of MH include hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, hyperkalaemia, muscle rigidity, and rhabdomyolysis, all related to a hypermetabolic response. The syndrome is likely to be fatal if untreated. An increase in end-tidal carbon dioxide despite increased minute ventilation provides an early diagnostic clue. In humans the syndrome is inherited in an autosomal dominant pattern, while in pigs it is autosomal recessive. Uncontrolled rise of myoplasmic calcium, which activates biochemical processes related to muscle activation leads to the pathophysiologic changes. In most cases, the syndrome is caused by a defect in the ryanodine receptor. Over 400 variants have been identified in the RYR1 gene located on chromosome 19q13.1, and at least 34 are causal for MH. Less than 1 % of variants have been found in CACNA1S but not all of these are causal. Diagnostic testing involves the in vitro contracture response of biopsied muscle to halothane, caffeine, and in some centres ryanodine and 4-chloro-m-cresol. Elucidation of the genetic changes has led to the introduction of DNA testing for susceptibility to MH. Dantrolene sodium is a specific antagonist and should be available wherever general anesthesia is administered. Increased understanding of the clinical manifestation and pathophysiology of the syndrome, has lead to the mortality decreasing from 80 % thirty years ago to <5 % in 2006. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. The effect of succinylcholine on malignant hyperthermia events in susceptible swine.
- Author
-
Schuster, Frank, Johannsen, Stephan, Moegele, Susanne, Metterlein, Thomas, Roewer, Norbert, and Anetseder, Martin
- Subjects
- *
SUCCINYLCHOLINE , *MALIGNANT hyperthermia , *NEUROMUSCULAR depolarizing agents , *HALOTHANE , *ACADEMIC medical centers , *ANALYSIS of variance , *ANIMAL experimentation , *BLOOD gases analysis , *COMBINATION drug therapy , *GENETIC mutation , *STATISTICS , *SWINE , *DATA analysis , *THERAPEUTICS , *GENETICS , *PREVENTION - Abstract
Background While the impact of volatile anaesthetics to induce malignant hyperthermia (MH) is abundantly clear, the role of succinylcholine still remains controversial. To evaluate the influence of succinylcholine on porcine MH events, the authors investigated the hemodynamic and metabolic responses in MH susceptible (MHS) and non-susceptible (MHN) swine following either succinylcholine or halothane application alone or a combination of both substances. Methods With approval of the local animal care committee 27 MHS and 30 MHN pigs were anaesthetized and mechanically ventilated. Fiberoptic probes for continuous PCO2 measurement were inserted into the femoral vein and the triceps muscle. Group A received succinylcholine 4 mg/kg, group B incremental doses of halothane (0.5, 1.0 vol%) and group C succinylcholine and halothane simultaneously. Vital signs were recorded continuously. Results Prior to drug application measured values did not differ between MHS and MHN. While MHN pigs did not show relevant alterations, succinylcholine, halothane and the combination of both lead to significant hemodynamic and metabolic changes in MHS swine. Conclusions Hemodynamic and metabolic alterations following succinylcholine were similar to halothane in MHS pigs. The combination of both pharmacological agents potentiated the observed effects. According to these results succinylcholine acted as an independent and supportive factor during onset of an MH episode. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
- Author
-
Klingler, Werner, Heiderich, Sebastian, Girard, Thierry, Gravino, Elvira, Heffron, James J. A., Johannsen, Stephan, Jurkat-Rott, Karin, Rüffert, Henrik, Schuster, Frank, Snoeck, Marc, Sorrentino, Vincenzo, Tegazzin, Vincenzo, and Lehmann-Horn, Frank
- Subjects
- *
MALIGNANT hyperthermia , *ANESTHESIA complications , *ADMINISTRATION of anesthetics , *HUMAN chromosome abnormality diagnosis , *CENTRAL nervous system depressants , *SUCCINYLCHOLINE - Abstract
Background Malignant hyperthermia (MH) is a rare pharmacogenetic disorder which is characterized by life-threatening metabolic crises during general anesthesia. Classical triggering substances are volatile anesthetics and succinylcholine (SCh). The molecular basis of MH is excessive release of Ca2+ in skeletal muscle principally by a mutated ryanodine receptor type 1 (RyR1). To identify factors explaining the variable phenotypic presentation and complex pathomechanism, we analyzed proven MH events in terms of clinical course, muscle contracture, genetic factors and pharmocological triggers. Methods In a multi-centre study including seven European MH units, patients with a history of a clinical MH episode confirmed by susceptible (MHS) or equivocal (MHE) in vitro contracture tests (IVCT) were investigated. A test result is considered to be MHE if the muscle specimens develop pathological contractures in response to only one of the two test substances, halothane or caffeine. Crises were evaluated using a clinical grading scale (CGS), results of IVCT and genetic screening. The effects of SCh and volatile anesthetics on Ca2+ release from sarcoplasmic reticulum (SR) were studied in vitro. Results A total of 200 patients met the inclusion criteria. Two MH crises (1%) were triggered by SCh (1 MHS, 1 MHE), 18% by volatile anesthetics and 81% by a combination of both. Patients were 70% male and 50% were younger than 12 years old. Overall, CGS was in accord with IVCT results. Crises triggered by enflurane had a significantly higher CGS compared to halothane, isoflurane and sevoflurane. Of the 200 patients, 103 carried RyR1 variants, of which 14 were novel. CGS varied depending on the location of the mutation within the RyR1 gene. In contrast to volatile anesthetics, SCh did not evoke Ca2+ release from isolated rat SR vesicles. Conclusions An MH event could depend on patient-related risk factors such as male gender, young age and causative RyR1 mutations as well as on the use of drugs lowering the threshold of myoplasmic Ca2+ release. SCh might act as an accelerant by promoting unspecific Ca2+ influx via the sarcolemma and indirect RyR1 activation. Most MH crises develop in response to the combined administration of SCh and volatile anesthetics. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. The optimal dose of succinylcholine for rapid sequence induction: a systematic review and meta-analysis of randomized trials
- Author
-
Alessandro Putzu, Christoph Czarnetzki, Maxim Giffa, and Martin R. Tramèr
- Subjects
Suxamethonium ,medicine.medical_treatment ,Succinylcholine ,General anaesthesia ,law.invention ,lcsh:RD78.3-87.3 ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,030202 anesthesiology ,law ,Medicine ,Humans ,Rapid Sequence Induction and Intubation ,Randomized Controlled Trials as Topic ,Dose-Response Relationship, Drug ,business.industry ,Tracheal intubation ,Absolute risk reduction ,Rapid sequence induction ,Study heterogeneity ,Regimen ,Anesthesiology and Pain Medicine ,lcsh:Anesthesiology ,Meta-analysis ,Anesthesia ,Neuromuscular Depolarizing Agents ,business ,030217 neurology & neurosurgery ,Research Article - Abstract
Background The evidence base for the widely accepted standard regimen of succinylcholine for rapid sequence induction (1.0 mg kg− 1) remains unclear. Methods We performed a systematic review and meta-analysis of randomized trials comparing any succinylcholine regimen with the standard regimen (1.0 mg kg− 1) and reporting on intubating conditions and/or apnoea times. Results were expressed as absolute risk differences (ARD) for dichotomous data and mean differences (MD) for continuous data. Results We retrieved six trials with relevant data of 864 patients (ASA 1 or 2, aged 18–65 years, body mass index − 2). Four regimens (0.3, 0.4, 0.5, 0.6 mg kg− 1) were compared with 1.0 mg kg− 1 in at least three trials each, and three (0.8, 1.5, 2 mg kg− 1) in one each. With 0.3 to 0.5 mg kg− 1, the likelihood of excellent intubating conditions was significantly decreased (ARD − 22% to − 67%). With 0.3 and 0.4 mg kg− 1, but not with 0.5, 0.6, 0.8, 1.5 and 2.0 mg kg− 1, the likelihood of unacceptable intubating conditions was significantly increased (ARD + 22% and + 32%, respectively). With 2.0 mg kg− 1, but not with 0.8 or 1.5 mg kg− 1, the likelihood of excellent intubating conditions was significantly increased (ARD + 23%). Apnoea times were significantly shorter with regimens ≤0.8 mg kg− 1 (MD − 1.0 to − 3.4 min) but were not reported with 1.5 or 2.0 mg kg− 1. Conclusions With succinylcholine regimens ≤0.5 mg kg− 1, excellent intubating conditions are less likely and apnoea times are shorter, compared with 1 mg kg− 1. With 0.3 and 0.4 mg kg− 1, unacceptable intubating conditions are more common. Succinylcholine 1.5 mg kg− 1 does not produce more often excellent conditions compared with 1 mg kg− 1, while 2.0 mg kg− 1 does, but the database with these regimens is weak and apnoea times remain unknown. Limited information size and strong statistical heterogeneity decrease the certainty of the evidence.
- Published
- 2020
16. Evaluation of suspected malignant hyperthermia events during anesthesia.
- Author
-
Schuster, Frank, Johannsen, Stephan, Schneiderbanger, Daniel, and Roewer, Norbert
- Subjects
- *
SUCCINYLCHOLINE , *ACADEMIC medical centers , *BIOPSY , *BLOOD gases analysis , *CONTRACTURE (Pathology) , *DANTROLENE , *DOSE-response relationship in biochemistry , *MALIGNANT hyperthermia , *MEDICAL records , *MUSCLES , *NEUROMUSCULAR depolarizing agents , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *GENERAL anesthesia , *DIAGNOSIS - Abstract
Background: Malignant hyperthermia (MH), a metabolic myopathy triggered by volatile anesthetics and depolarizing muscle relaxants, is a potentially lethal complication of general anesthesia in susceptible patients. The implementation of modern inhalation anesthetics that research indicates as less potent trigger substances and the recommended limitations of succinylcholine use, suggests there may be considerable decline of fulminant MH cases. In the presented study, the authors analyzed suspected MH episodes during general anesthesia of patients that were referred to the Wuerzburg MH unit between 2007 and 2011, assuming that MH is still a relevant anesthetic problem in our days. Methods: With approval of the local ethics committee data of patients that underwent muscle biopsy and in vitro contracture test (IVCT) between 2007 and 2011 were analyzed. Only patients with a history of suspected MH crisis were included in the study. The incidents were evaluated retrospectively using anesthetic documentation and medical records. Results: Between 2007 and 2011 a total of 124 patients were tested. 19 of them were referred because of suspected MH events; 7 patients were diagnosed MH-susceptible, 4 MH-equivocal and 8 MH-non-susceptible by IVCT. In a majority of cases masseter spasm after succinylcholine had been the primary symptom. Cardiac arrhythmias and hypercapnia frequently occurred early in the course of events. Interestingly, dantrolene treatment was initiated in a few cases only. Conclusions: MH is still an important anesthetic complication. Every anesthetist must be aware of this life-threatening syndrome at any time. The rapid onset of adequate therapy is crucial to avoid major harm and possibly lethal outcome. Dantrolene must be readily available wherever MH triggering agents are used for anesthesia. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. A comparison of three induction regimens using succinylcholine, vecuronium, or no muscle relaxant: impact on the intraoperative monitoring of the lateral spread response in hemifacial spasm surgery: study protocol for a randomised controlled trial.
- Author
-
Yuan Fang, Heng Zhang, Wenke Liu, and Yu Li
- Subjects
- *
VECURONIUM bromide , *RANDOMIZED controlled trials , *ANESTHESIA , *INTUBATION , *ARTIFICIAL feeding , *SUCCINYLCHOLINE - Abstract
Background: Surgical microvascular decompression (MVD) is the curative treatment for hemifacial spasm (HFS). Monitoring MVD by recording the lateral spread response (LSR) intraoperatively can predict a successful clinical outcome. However, the rate of the LSR varies between trials, and the reason for this variation is unclear. The aim of our trial is to evaluate the rate of the LSR after intubation following treatment with succinylcholine, vecuronium, or no muscle relaxant. Methods and design: This trial is a prospective randomised controlled trial of 96 patients with HFS (ASA status I or II) undergoing MVD under general anaesthesia. Patients are randomised to receive succinylcholine, vecuronium, or no muscle relaxant before intubation. Intraoperative LSR will be recorded until dural opening. The primary outcome of this study is the rate of the LSR, and the secondary outcomes are post-intubation pharyngolaryngeal symptoms, the rate of difficult intubations, the rate of adverse haemodynamic events and the relationship between the measurement of LSR or not, and clinical success rates at 30 days after surgery. Discussion: This study aims to evaluate the impact of muscle relaxants on the rate of the LSR, and the study may provide evidence supporting the use of muscle relaxants before intubation in patients with HFS undergoing MVD surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
18. Looking Back on the Discovery of α-Bungarotoxin.
- Author
-
Chang, C. C.
- Subjects
- *
BUNGAROTOXIN , *NEUROMUSCULAR blocking agents , *NICOTINIC receptors , *DESENSITIZATION (Psychotherapy) , *ACETYLCHOLINE , *TUBOCURARINE - Abstract
This review is a personal narration by a retiring pharmacologist from Taiwan who looks back at his discovery of α-bungarotoxin from the historical perspective of Taiwan during the last 50 years, with accounts of his experiences and his efforts to overcome hardship. How the α-toxin was isolated and characterized as an irreversible specific nicotinic acetylcholine (ACh) receptor antagonist, and how it subsequently became a useful experimental probe are presented here. The dilemma of differentiating the actions of tubocurarine and α-bungarotoxin is analyzed. The author also outlines findings based on work done in his laboratory using α-bungarotoxin as a tool on particular aspects of synaptic transmission. These include presynaptic receptor for positive feedback of transmitter release, explosive release of ACh, up- and downregulation of ACh receptors after chronic drug treatment, autodesensitization of junctional ACh receptors, differences in action between natural transmitter and exogenous agonists and that between junctional and extrajunctional ACh receptors. Some experimental pitfalls, in which biomedical scientists are frequently trapped, are raised. Finally, some anecdotes are appended from which the reader may further understand scientific life in the 20th century, including its joys and regrets. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
19. Significant modification of traditional rapid sequence induction improves safety and effectiveness of pre-hospital trauma anaesthesia
- Author
-
Debamoy Chatterjee, David Lockey, Malcolm Q. Russell, Richard Lyon, and Zane Perkins
- Subjects
Adult ,Male ,medicine.medical_specialty ,Emergency Medical Services ,Adolescent ,medicine.medical_treatment ,Laryngoscopy ,Succinylcholine ,Critical Care and Intensive Care Medicine ,Fentanyl ,Young Adult ,Etomidate ,medicine ,Intubation, Intratracheal ,Intubation ,Humans ,Anesthesia ,Androstanols ,Rocuronium ,Child ,Aged ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Major trauma ,Research ,Tracheal intubation ,Infant ,Middle Aged ,medicine.disease ,Rapid sequence induction ,Surgery ,Child, Preschool ,Female ,Ketamine ,business ,Anesthetics, Intravenous ,medicine.drug ,Neuromuscular Nondepolarizing Agents - Abstract
Introduction Rapid Sequence Induction of anaesthesia (RSI) is the recommended method to facilitate emergency tracheal intubation in trauma patients. In emergency situations, a simple and standardised RSI protocol may improve the safety and effectiveness of the procedure. A crucial component of developing a standardised protocol is the selection of induction agents. The aim of this study is to compare the safety and effectiveness of a traditional RSI protocol using etomidate and suxamethonium with a modified RSI protocol using fentanyl, ketamine and rocuronium. Methods We performed a comparative cohort study of major trauma patients undergoing pre-hospital RSI by a physician-led Helicopter Emergency Medical Service. Group 1 underwent RSI using etomidate and suxamethonium and Group 2 underwent RSI using fentanyl, ketamine and rocuronium. Apart from the induction agents, the RSI protocol was identical in both groups. Outcomes measured included laryngoscopy view, intubation success, haemodynamic response to laryngoscopy and tracheal intubation, and mortality. Results Compared to Group 1 (n = 116), Group 2 RSI (n = 145) produced significantly better laryngoscopy views (p = 0.013) and resulted in significantly higher first-pass intubation success (95% versus 100%; p = 0.007). A hypertensive response to laryngoscopy and tracheal intubation was less frequent following Group 2 RSI (79% versus 37%; p Conclusions In a comparative, cohort study, pre-hospital RSI using fentanyl, ketamine and rocuronium produced superior intubating conditions and a more favourable haemodynamic response to laryngoscopy and tracheal intubation. An RSI protocol using fixed ratios of these agents delivers effective pre-hospital trauma anaesthesia.
- Published
- 2015
20. Entrapment of a laryngotracheal topical anesthesia kit during tracheobronchial foreign body removal: a case report.
- Author
-
Zhang, Xi-Yang, Han, Yun, Zhang, Ya-Bing, Liu, Ke-Xuan, and Liu, Bin
- Subjects
- *
TRACHEAL surgery , *REACTIVE oxygen species , *ANESTHESIA , *ATROPINE , *FOREIGN bodies , *HEART beat , *INTRAVENOUS therapy , *OXYGEN in the body , *RESPIRATORY obstructions , *SURGICAL complications , *CUTANEOUS therapeutics , *DISCHARGE planning , *FOREIGN body migration , *DISEASE complications , *SUCCINYLCHOLINE , *THERAPEUTICS - Abstract
Background: In order to reduce the irritation of the airway during tracheobronchial foreign body (TFB) removal, tracheal surface anesthesia is usually performed using a laryngotracheal topical anesthesia (LTA) kit (LTA20, Highgreen Medical Technology Company, China), but difficulty in withdrawing the LTA kit is rarely reported. We present a case of a difficulty to withdraw the LTA kit due to its entrapment by the movement of a TFB. Case presentation: A 1-year-old girl was undergoing TFB removal. After the surgeon completed the tracheal surface anesthesia, the girl suddenly suffered from bucking, leading to the dislodgment of the TFB to the subglottic region, complicating the withdrawal of the LTA applicator. At the same time, the girl's oxygen saturation (SpO2) decreased to 91% and her heart rate dropped from 150 to 100 bpm. Atropine and succinylcholine were administered intravenously immediately, then the surgeon tried to free the TFB by pushing it back into the trachea, after which the LTA applicator was easily withdrawn, and TFB was removed successfully. The girl was discharged from hospital without any complications 2 days later. Conclusion: This case report draws our attention to a significant anesthetic clinical consideration during the application of topical anesthesia on the trachea for TFB removal. The possibility of coughing or bucking can lead to migration of the TFB with subsequent airway obstruction, so the depth of anesthesia must be sufficient to prevent harmful reflexes. Also, strong teamwork and good communication are paramount to avoid serious complications. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
21. Succinylcholine versus rocuronium for rapid sequence intubation in intensive care : a prospective, randomized controlled trial
- Author
-
Martin Siegemund, Luzius A. Steiner, Timothy Aebi, Hans Pargger, Stephan Marsch, Patrick Hunziker, Martin Schumann, and Evelyne Bucher
- Subjects
Adult ,Male ,Time Factors ,medicine.medical_treatment ,Succinylcholine ,Critical Care and Intensive Care Medicine ,Hypoxemia ,law.invention ,Hospitals, University ,Randomized controlled trial ,law ,Etomidate ,Intensive care ,Outcome Assessment, Health Care ,medicine ,Intubation, Intratracheal ,Intubation ,Humans ,Prospective Studies ,Androstanols ,Rocuronium ,Prospective cohort study ,Hypoxia ,Aged ,business.industry ,Research ,Middle Aged ,Rapid sequence induction ,Intensive Care Units ,Anesthesia ,Neuromuscular Depolarizing Agents ,Commentary ,Female ,medicine.symptom ,business ,medicine.drug ,Neuromuscular Nondepolarizing Agents - Abstract
Introduction Succinylcholine and rocuronium are widely used to facilitate rapid sequence induction (RSI) intubation in intensive care. Concerns relate to the side effects of succinylcholine and to slower onset and inferior intubation conditions associated with rocuronium. So far, succinylcholine and rocuronium have not been compared in an adequately powered randomized trial in intensive care. Accordingly, the aim of the present study was to compare the incidence of hypoxemia after rocuronium or succinylcholine in critically ill patients requiring an emergent RSI. Methods This was a prospective randomized controlled single-blind trial conducted from 2006 to 2010 at the University Hospital of Basel. Participants were 401 critically ill patients requiring emergent RSI. Patients were randomized to receive 1 mg/kg succinylcholine or 0.6 mg/kg rocuronium for neuromuscular blockade. The primary outcome was the incidence of oxygen desaturations defined as a decrease in oxygen saturation ≥ 5%, assessed by continuous pulse oxymetry, at any time between the start of the induction sequence and two minutes after the completion of the intubation. A severe oxygen desaturation was defined as a decrease in oxygen saturation ≥ 5% leading to a saturation value of ≤ 80%. Results There was no difference between succinylcholine and rocuronium regarding oxygen desaturations (succinylcholine 73/196; rocuronium 66/195; P = 0.67); severe oxygen desaturations (succinylcholine 20/196; rocuronium 20/195; P = 1.0); and extent of oxygen desaturations (succinylcholine -14 ± 12%; rocuronium -16 ± 13%; P = 0.77). The duration of the intubation sequence was shorter after succinycholine than after rocuronium (81 ± 38 sec versus 95 ± 48 sec; P = 0.002). Intubation conditions (succinylcholine 8.3 ± 0.8; rocuronium 8.2 ± 0.9; P = 0.7) and failed first intubation attempts (succinylcholine 32/200; rocuronium 36/201; P = 1.0) did not differ between the groups. Conclusions In critically ill patients undergoing emergent RSI, incidence and severity of oxygen desaturations, the quality of intubation conditions, and incidence of failed intubation attempts did not differ between succinylcholine and rocuronium. Trial Registration ClinicalTrials.gov, number NCT00355368.
- Published
- 2011
- Full Text
- View/download PDF
22. A comparison of three induction regimens using succinylcholine, vecuronium, or no muscle relaxant: impact on the intraoperative monitoring of the lateral spread response in hemifacial spasm surgery: study protocol for a randomised controlled trial
- Author
-
Yu Li, Heng Zhang, Wenke Liu, and Yuan Fang
- Subjects
Male ,Time Factors ,medicine.medical_treatment ,Medicine (miscellaneous) ,Facial Muscles ,Electromyography ,law.invention ,Microvascular Decompression Surgery ,Study Protocol ,Randomized controlled trial ,law ,Intubation ,Pharmacology (medical) ,Prospective Studies ,Intraoperative monitoring ,lcsh:R5-920 ,medicine.diagnostic_test ,Muscle relaxant ,Facial Nerve ,Treatment Outcome ,Research Design ,Anesthesia ,Female ,Vecuronium bromide ,lcsh:Medicine (General) ,medicine.drug ,medicine.medical_specialty ,China ,medicine.drug_class ,Microvascular decompression ,Succinylcholine ,Anesthesia, General ,Monitoring, Intraoperative ,medicine ,Vecuronium ,Intubation, Intratracheal ,Humans ,Hemifacial Spasm ,Vecuronium Bromide ,business.industry ,medicine.disease ,Electric Stimulation ,Surgery ,Neuromuscular Depolarizing Agents ,business ,Hemifacial spasm ,Lateral spread response - Abstract
Background Surgical microvascular decompression (MVD) is the curative treatment for hemifacial spasm (HFS). Monitoring MVD by recording the lateral spread response (LSR) intraoperatively can predict a successful clinical outcome. However, the rate of the LSR varies between trials, and the reason for this variation is unclear. The aim of our trial is to evaluate the rate of the LSR after intubation following treatment with succinylcholine, vecuronium, or no muscle relaxant. Methods and design This trial is a prospective randomised controlled trial of 96 patients with HFS (ASA status I or II) undergoing MVD under general anaesthesia. Patients are randomised to receive succinylcholine, vecuronium, or no muscle relaxant before intubation. Intraoperative LSR will be recorded until dural opening. The primary outcome of this study is the rate of the LSR, and the secondary outcomes are post-intubation pharyngolaryngeal symptoms, the rate of difficult intubations, the rate of adverse haemodynamic events and the relationship between the measurement of LSR or not, and clinical success rates at 30 days after surgery. Discussion This study aims to evaluate the impact of muscle relaxants on the rate of the LSR, and the study may provide evidence supporting the use of muscle relaxants before intubation in patients with HFS undergoing MVD surgery. Trials registration http://www.chictr.org/ ChiCTR-TRC-11001504 Date of registration: 24 June, 2011. The date the first patient was randomised: 30 September, 2011.
- Published
- 2012
23. Is succinylcholine appropriate or obsolete in the intensive care unit?
- Author
-
Booij, Leo HDJ
- Subjects
Intensive Care Units ,cholinesterase ,succinylcholine ,neuromuscular nondepolarizing agents ,Neuromuscular Depolarizing Agents ,Commentary ,Humans ,intubation ,depolarizing muscle relaxants - Abstract
Muscle relaxants in intensive care unit (ICU) patients are predominantly administered to facilitate intubation. The adverse effect profile of succinylcholine is such that its use in the ICU must be considered obsolete. Suitable alternatives are the intermediately long-acting nondepolarizing relaxants, of which rocuronium is probably preferable.
- Published
- 2001
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.